The Supply Chain and Logistics for B2B market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031. Considering the influence of COVID-19 on the global Supply Chain and Logistics for B2B market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions. This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery. Under COVID-19 Outbreak, how the Supply Chain and Logistics for B2B Industry will develop is also analyzed in detail in Chapter 1.8 of this report. Major Players in Supply Chain and Logistics for B2B market are: Robinson FedEx Corp Panalpina Welttransport Holding AG CEVA Logistics Kuehne + Nagel International AG UPS Supply Chain Solutions Delhivery GEODIS Gati DHL Supply Chain Ryder System, Inc. DB Schenker Nippon Express XPO Logistics J.B. Hunt Transport Services Deutsche Post-DHL Group Maersk Group Most important types of Supply Chain and Logistics for B2B products covered in this report are: Storage & Warehouse Transportation Most widely used downstream fields of Supply Chain and Logistics for B2B market covered in this report are: Manufacturing Trade and Transportation Government and Public Utilities Retailing Others Major Regions or countries covered in this report: North America Europe China Japan Middle East and Africa South America India South Korea Southeast Asia Others In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations. In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out. In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.